29 active
/
123 total (since 2015)
3
Phase 1 Active
39 total
14
Phase 2 Active
44 total
13
Phase 3 Active
33 total
5
Phase 4 Active
17 total
Top Sponsors (Industry)
Sorted by active Active Done Failed
Mundipharma Research Limited 2 0 1
F2G Biotech GmbH 1 9 4
Basilea Pharmaceutica 1 5 1
Merck 1 3 0
LimmaTech Biologics AG 1 0 0
pH-D Feminine Health LLC 1 0 0
Biosergen AS 1 0 0
AVVA Pharmaceuticals Ltd. 1 0 0
Fujian Shengdi Pharmaceutical Co., Ltd. 1 0 0
NEXBIOME THERAPEUTICS 1 0 0
Scynexis, Inc. 0 7 2
Pulmocide Ltd 0 2 3
Mycovia Pharmaceuticals Inc. 0 3 0
Matinas BioPharma Nanotechnologies, Inc. 0 2 1
Cidara Therapeutics Inc. 0 3 0
NCT05421858 RECRUITING
A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis.
Basilea Pharmaceutica n=450
NCT07109869 RECRUITING
Safety and Efficacy of Boric Acid Inserts for Treatment of Vulvovaginal Candidiasis
pH-D Feminine Health LLC n=400
NCT04368559 ACTIVE NOT RECRUITING
Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation
Mundipharma Research Limited n=602
NCT06774144 ENROLLING BY INVITATION
Rezafungin Prophylaxis in Liver Transplant
Fernanda P Silveira, MD, MS n=385
NCT06174922 RECRUITING
A Randomized Trial of Prednisolone, Itraconazole, or Their Combination in Allergic Bronchopulmonary Aspergillosis
Post Graduate Institute of Medical Education and Research, Chandigarh n=300
NCT04227483 ACTIVE NOT RECRUITING
Deflazacort Vs. Prednisolone in Acute-stage ABPA
Post Graduate Institute of Medical Education and Research, Chandigarh n=150
NCT03656081 RECRUITING
Chronic Pulmonary Aspergillosis and Ambisome Aerosol with Itraconazole
Poitiers University Hospital n=224
NCT06835361 RECRUITING
Efficacy and Safety of Clotrimazole+Lactulose Vaginal Suppositories Vs. Clotrimazole Monotherapy in Adult Women with Candidal Vaginitis/Vulvovaginitis
AVVA Pharmaceuticals Ltd. n=264
NCT05814432 RECRUITING
Efficacy and Safety of High-dose Liposomal Amphotericin B for Disseminated Histoplasmosis in AIDS
Federal University of Health Science of Porto Alegre n=279
NCT06447402 RECRUITING
A Trial to Compare Nebulized Amphotericin B and Nebulized Normal Saline as Maintenance in Patients With Chronic Pulmonary Aspergillosis
Post Graduate Institute of Medical Education and Research, Chandigarh n=196
NCT05367089 RECRUITING
The Effect of Medical Grade Honey Formulation (L-Mesitran) Administration on Recurrent Vulvovaginal Candidiasis Symptoms
Maastricht University Medical Center n=252
NCT03562156 COMPLETED
A Study of Oral Oteseconazole for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection)
Mycovia Pharmaceuticals Inc. n=438
NCT03561701 COMPLETED
A Study of Oral Oteseconazole (VT-1161) for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection)
Mycovia Pharmaceuticals Inc. n=425
NCT05178862 TERMINATED
A Phase 3, Randomized, Double-blind Study for Patients With Invasive Candidiasis Treated With IV Echinocandin Followed by Either Oral Ibrexafungerp or Oral Fluconazole
Scynexis, Inc. n=68
NCT05707832 COMPLETED
A Study of ABCD for Injection in Subjects With Invasive Candidiasis and Invasive Aspergillus
CSPC Ouyi Pharmaceutical Co., Ltd. n=31
NCT03059992 COMPLETED
Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment
Scynexis, Inc. n=233
NCT04824417 COMPLETED
A Randomized Controlled Trial to Compare the Clinical Outcomes With Six Months of Therapy With Oral Itraconazole Versus Oral Voriconazole for Management of Treatment naïve Subjects With Chronic Pulmonary Aspergillosis
Post Graduate Institute of Medical Education and Research, Chandigarh n=116
NCT05399641 COMPLETED
Ibrexafungerp for the Treatment of Complicated Vulvovaginal Candidiasis
Scynexis, Inc. n=150
NCT03363841 COMPLETED
Open-Label Study to Evaluate the Efficacy and Safety of Oral Ibrexafungerp (SCY-078) in Patients With Candidiasis Caused by Candida Auris (CARES)
Scynexis, Inc. n=30
NCT06411314 COMPLETED
Efficacy and Safety of Natamycin and Lactulose Vaginal Suppositories in Treatment of Vulvovaginal Candidiasis
Avva Rus, JSC n=218
NCT04876716 TERMINATED
Azole-echinocandin Combination Therapy for Invasive Aspergillosis
Erasmus Medical Center n=66
NCT03572049 COMPLETED
Endemic Mycoses Treatment With SUBA-itraconazole vs Itraconazole
University of Alabama at Birmingham n=88
NCT04029116 COMPLETED
Phase 3 Study of Oral Ibrexafungerp (SCY-078) Vs. Placebo in Subjects With Recurrent Vulvovaginal Candidiasis (VVC)
Scynexis, Inc. n=440
NCT03667690 COMPLETED
Study of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive Candidiasis
Cidara Therapeutics Inc. n=199
NCT04707703 TERMINATED
Isavuconazole for the Prevention of COVID-19-associated Pulmonary Aspergillosis
Jeffrey Jenks, MD, MPH n=8
NCT03840616 COMPLETED
Study of Oral Oteseconazole (VT-1161) for Acute Yeast Infections in Patients With Recurrent Yeast Infections
Mycovia Pharmaceuticals Inc. n=219
NCT02879305 COMPLETED
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Dialysis (ASCEND-D)
GlaxoSmithKline n=2,964
NCT03920527 COMPLETED
Six Months Versus 12 Months of Oral Itraconazole Therapy for Management of Treatment naïve Subjects With CPA
Post Graduate Institute of Medical Education and Research, Chandigarh n=164
NCT02907307 WITHDRAWN
Efficacy, Safety LactiSal 1% Gel, LactSal 50 mg, Clotrimazole 100 mg Tablet in Treatment Vulvovaginal Candidiasis
Medinova AG
NCT02818803 COMPLETED
Efficacy of Standardized-propolis Extract (EPP-AF®) Gel Formulation as Buccal Antiseptic
University of Sao Paulo n=40
Data: ClinicalTrials.gov